According to Embla Medical's latest financial reports the company's current EPS (TTM) is โน9.81. In 2023 the company made an earnings per share (EPS) of โน12.05 an increase over its 2022 EPS that were of โน8.86.
Year | EPS | Change |
---|---|---|
2024 (TTM) | โน9.42 | -21.82% |
2023 | โน12.05 | 35.92% |
2022 | โน8.86 | -33.97% |
2021 | โน13.42 | 958.85% |
2020 | โน1.27 | -90.55% |
2019 | โน13.42 | -17.03% |
2018 | โน16.18 | 40.3% |
2017 | โน11.53 | 15.52% |
2016 | โน9.98 | 0.87% |
2015 | โน9.90 | -12.88% |
2014 | โน11.36 | 45.05% |
2013 | โน7.83 | 8.33% |
2012 | โน7.23 | 9.09% |
2011 | โน6.63 | -1.16% |
2010 | โน6.70 | 46.43% |
2009 | โน4.58 | -21.07% |
2008 | โน5.80 | 247.42% |
2007 | โน1.67 | 71.68% |
2006 | โน0.97 | -67.99% |
2005 | โน3.04 | -26.46% |
2004 | โน4.13 | 231.03% |
2003 | โน1.25 | -53.53% |
2002 | โน2.68 |